Cai Kathy Qi, Klein-Szanto Andres, Karthik Devarajan, Edelson Mitchell, Daly Mary B, Ozols Robert F, Lynch Henry T, Godwin Andrew K, Xu Xiang-Xi
Ovarian Cancer Program and Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Gynecol Oncol. 2006 Nov;103(2):719-28. doi: 10.1016/j.ygyno.2006.03.053. Epub 2006 May 12.
From analysis of pre-cancer ovarian tissues obtained from prophylactic oophorectomies, several studies reported the increased ovarian morphological changes in high-risk ovaries, but whether these morphological changes are associated with BRCA1/BRCA2 genotypes or are cancer precursors is controversial. Here, we have investigated a recent collection of ovaries from prophylactic oophorectomies and control ovaries from surgeries due to other non-ovarian-related cancer or non-neoplastic diseases to determine if ovarian morphological changes relate to BRCA1/2 genotypes or reproductive history.
We assembled a panel of archived ovarian tissues: 52 ovarian tissue blocks were from prophylactic oophorectomies of a high-risk (HR) population; 66 ovaries were from surgeries due to non-ovarian-related diseases, referred to as normal-risk (NR) group. The morphology of ovarian tissues was examined, and morphological changes including papillomatosis, invaginations, inclusion cysts, and epithelial stratification were assessed in a blinded fashion.
No statistically significant difference in frequency of these histolopathologic features was found between HR and NR groups. However, inclusion cysts and deep invaginations were found much more commonly in women age 45-54 of either HR or NR groups.
This study suggests that no significant increase in the presence of non-neoplastic ovarian morphological changes is associated with BRCA1/BRCA2 mutations. Rather, the frequency of these histological features, especially inclusion cysts, may associate with age or menopausal status. We propose that ovulatory and perimenopausal gonadotropin stimulation produces ovarian morphological changes, and these histological features may promote the transformation of genetically compromised epithelial cells in the development of ovarian cancer.
通过对预防性卵巢切除术获取的癌前卵巢组织进行分析,多项研究报告称高危卵巢中卵巢形态学变化有所增加,但这些形态学变化是否与BRCA1/BRCA2基因型相关或是否为癌症前体存在争议。在此,我们研究了近期一批来自预防性卵巢切除术的卵巢以及因其他非卵巢相关癌症或非肿瘤性疾病手术获取的对照卵巢,以确定卵巢形态学变化是否与BRCA1/2基因型或生殖史有关。
我们收集了一组存档的卵巢组织:52个卵巢组织块来自高危(HR)人群的预防性卵巢切除术;66个卵巢来自因非卵巢相关疾病进行的手术,称为正常风险(NR)组。检查卵巢组织的形态,并以盲法评估包括乳头瘤病、内陷、包涵囊肿和上皮分层在内的形态学变化。
HR组和NR组之间这些组织病理学特征的频率没有统计学上的显著差异。然而,在HR组或NR组年龄45 - 54岁的女性中,包涵囊肿和深部内陷更为常见。
本研究表明,非肿瘤性卵巢形态学变化的存在没有因BRCA1/BRCA2突变而显著增加。相反,这些组织学特征的频率,尤其是包涵囊肿,可能与年龄或绝经状态有关。我们提出排卵和围绝经期促性腺激素刺激会产生卵巢形态学变化,并且这些组织学特征可能在卵巢癌发生发展过程中促进基因受损的上皮细胞转化。